Arrowstreet Capital’s LeMaitre Vascular LMAT Stock Holding History

Arrowstreet Capital’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-9,833	Closed	-$906K	–	1923
2024 Q4	$906K	Buy	9,833 +6,937	+240%	+$667K	﹤0.01%	1475
2024 Q3	$269K	Buy	+2,896	New	+$251K	﹤0.01%	1616
2023 Q3	–	Sell	-6,531	Closed	-$439K	–	1340
2023 Q2	$439K	Buy	+6,531	New	+$398K	﹤0.01%	1081
2021 Q4	–	Sell	-16,433	Closed	-$872K	–	1595
2021 Q3	$872K	Buy	+16,433	New	+$926K	﹤0.01%	1328
2021 Q1	–	Sell	-5,621	Closed	-$228K	–	2395
2020 Q4	$228K	Buy	+5,621	New	+$201K	﹤0.01%	2171
2019 Q2	–	Sell	-12,688	Closed	-$393K	–	1558
2019 Q1	$393K	Buy	+12,688	New	+$339K	﹤0.01%	1545
2018 Q2	–	Sell	-9,700	Closed	-$351K	–	1211
2018 Q1	$351K	Buy	+9,700	New	+$336K	﹤0.01%	998
2017 Q2	–	Sell	-19,400	Closed	-$478K	–	1213
2017 Q1	$478K	Buy	+19,400	New	+$455K	﹤0.01%	1096
2016 Q4	–	Sell	-42,135	Closed	-$836K	–	2147
2016 Q3	$836K	Buy	+42,135	New	+$736K	﹤0.01%	1117

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital's LMAT Position: Q1 2025 in Review

Arrowstreet Capital sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 9,833 shares — an estimated $906K sold.

Arrowstreet Capital first reported a position in LMAT in Q3 2016 and held it in 9 quarters. The position peaked at $906K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

Arrowstreet Capital reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
Arrowstreet Capital sold 9,833 LeMaitre Vascular shares in Q1 2025, an estimated $906K.
Arrowstreet Capital first reported a position in LeMaitre Vascular in Q3 2016 and held it in 9 quarters.
Arrowstreet Capital's LeMaitre Vascular position peaked at $906K in Q4 2024.
288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Arrowstreet Capital's 13F filing for Q1 2025, filed 14 May 2025.